Guangdong Kangda Pharmaceutical Co., Ltd   Report issue

For profit Phase 1
Founded: Shanghai China (2013)
Status: Left NME R&D (2019)

Organization Overview

First Clinical Trial
2018
NCT03804749
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Guangdong Kangda Pharmaceutical Co., Ltd

Active Ingredients

Drugs in Phase 1 Trials (1)

suramin (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Foot-and-Mouth Disease (Phase 1)

Hand, Foot and Mouth Disease (Phase 1)

Mouth Diseases (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1